Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 146 pembrolizumab 118 Magnetic Resonance Spectroscopy 117 Cyclophosphamide 113 Biopsy 96 fludarabine 88 Nivolumab 52 Carboplatin 51 Cisplatin 47 Gemcitabine 46 Radiotherapy 41 venetoclax 40 Cetuximab 40 fludarabine phosphate 39 Paclitaxel 39 Ipilimumab 34 atezolizumab 33 Fluorouracil 33 Bevacizumab 32 Oxaliplatin 27 Leucovorin 27 Dexamethasone 26 durvalumab 25 X-Rays 25 Irinotecan 25 Radiation 24 Cytarabine 23 Azacitidine 23 Injections 22 Temozolomide 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Chromatography, High Pressure Liquid × 90 days × Clear all

NCT00646230 2026-04-14

IV Fenretinide

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡